Coinbase Jumps on Trump CLARITY Act Concession, but Passage Odds Dip; Fundamentals Still Unproven

What happened

On Monday, Coinbase shares surged nearly 10% to $191.50 after President Trump made a major concession on the CLARITY Act, while Bitcoin held steady, marking a 37% rebound from the year's low. However, the article's title and context indicate that the odds of the CLARITY Act actually passing are dipping, suggesting that the regulatory breakthrough is far from certain. This rally comes despite the DeepValue master report's 'POTENTIAL SELL' rating, which highlighted a Q1'26 net loss of $394M, a 50% decline in trading volume, and a valuation of 62.5x P/E with no margin of safety. The report emphasized that the stock's upside depends on two unproven factors: a successful opex reset in Q2'26 and accelerated CFTC approvals for US perpetual futures beyond BTC; neither has been definitively confirmed by this news. While the concession is directionally positive, the market appears to be pricing in regulatory clarity that may not materialize, leaving the stock vulnerable if the bill stalls or if upcoming earnings show continued losses.

Implication

The 10% jump reflects short-term sentiment around a possible regulatory win, but the article's own headline warns that passage odds are dipping, meaning the concession may not translate into law. The DeepValue report's bear case (30% probability) explicitly hinges on slow case-by-case CFTC review limiting derivatives adoption, which would cap revenue growth and keep GAAP losses persistent. With COIN at $191.50, it is above the base case implied value of $185 but still below the report's trim level of $220, suggesting limited upside without confirmed catalysts. The next critical data point is Q2'26 earnings (likely released by August 2026), which should show whether the ~700-employee restructuring actually reduced operating expenses and narrowed losses; if not, the stock could retest the $150 attractive entry level. Until there is concrete evidence of both regulatory throughput and cost discipline, maintain a cautious stance; the recent insider selling (CPO selling nearly all shares in May) adds to the skepticism.

Thesis delta

The news modestly increases the probability of the bull case (regulatory clarity accelerating derivatives), but the report's concern that passage odds are dipping tempers this shift. The core thesis remains 'POTENTIAL SELL' because the fundamental issues—net losses, high valuation, and unproven organic growth—are unchanged. We maintain a conviction of 4.0 but will reassess if the CLARITY Act passes and Q2'26 results show a meaningful improvement.